MF
STLNW

Magnetar Financial’s Starling Oncology Warrant STLNW Stock Holding History

Magnetar Financial’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-254,570
Closed -$323K – 1555
2021
Q3 		$323K Hold
254,570
– – ﹤0.01% 995
2021
Q2 		$440K Hold
254,570
– – ﹤0.01% 918
2021
Q1 		$305K Hold
254,570
– – ﹤0.01% 924
2020
Q4 		$496K Buy
+254,570
New +$439K 0.01% 562

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $278M AUM 50.01% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Magnetar Financial's STLNW Position: Q4 2021 in Review

Magnetar Financial sold out of Starling Oncology Warrant (STLNW) in Q4 2021, closing a stake of 254,570 shares — an estimated $323K sold.

Magnetar Financial first reported a position in STLNW in Q4 2020 and held it in 4 quarters. The position peaked at $496K in Q4 2020. 20 funds tracked by Wall St. Rank hold STLNW as of Q4 2021.

  • Magnetar Financial reported no remaining Starling Oncology Warrant position as of Q4 2021 after selling out during the quarter.
  • Magnetar Financial sold 254,570 Starling Oncology Warrant shares in Q4 2021, an estimated $323K.
  • Magnetar Financial first reported a position in Starling Oncology Warrant in Q4 2020 and held it in 4 quarters.
  • Magnetar Financial's Starling Oncology Warrant position peaked at $496K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q4 2021.

Based on Magnetar Financial's 13F filing for Q4 2021, filed 14 Feb 2022.